Barings’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Barings's DGX Position: Q3 2020 in Review
Barings sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 4,109 shares — an estimated $330K sold.
Barings first reported a position in DGX in Q2 2013 and held it in 29 quarters. The position peaked at $2.15M in Q1 2015. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.
- Barings reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
- Barings sold 4,109 Quest Diagnostics shares in Q3 2020, an estimated $330K.
- Barings first reported a position in Quest Diagnostics in Q2 2013 and held it in 29 quarters.
- Barings's Quest Diagnostics position peaked at $2.15M in Q1 2015.
- 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.
Based on Barings's 13F filing for Q3 2020, filed 12 Nov 2020.